Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Karolinska Management Changes

This article was originally published in Scrip

Executive Summary

Karolinska Development AB has appointed life science investor Viktor Drvota chief investment officer, while the company's deputy CEO and chief scientific officer, Terje Kalland, will retire from both positions – effective Dec. 31, 2015. Drvota was previously head of life science and a senior investment manager at SEB Venture Capital. Prior to this he was a practising cardiologist at Huddinge University Hospital in Stockholm for 11 years and associate professor in cardiology at Karolinska Institute, Stockholm, since 2002.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

SC063899

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel